---
category: news
title: "Two Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design"
excerpt: "Two papers, published in The Lancet and Nature, indicate that treatment with oral raloxifene, a selective estrogen receptor modulator (SERM) with"
publishedDateTime: 2022-07-26T07:53:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/two-clinical-studies-to-treat-mild-to-moderate-covid-19-at-home-reveal-value-of-exscalate-dompé-s-ai-platform-for-drug-design-1031614341"
webUrl: "https://markets.businessinsider.com/news/stocks/two-clinical-studies-to-treat-mild-to-moderate-covid-19-at-home-reveal-value-of-exscalate-dompé-s-ai-platform-for-drug-design-1031614341"
type: article
quality: 41
heat: 41
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Facebook AI
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1865797/Dompe_Exscalate.jpg"
    width: 400
    height: 226
    isCached: true

secured: "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;GbCw3oajUyMtEB8MjtzYxA=="
---

